Bronchoalveolar Lavage Fluid Cellular Characteristics, Functional Parameters and Cytokine and Chemokine Levels in Interstitial Lung Diseases
Open Access
- 8 February 2009
- journal article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 69 (3) , 268-274
- https://doi.org/10.1111/j.1365-3083.2008.02222.x
Abstract
Idiopathic pulmonary fibrosis (IPF), hypersensitivity pneumonitis (HP) and sarcoidosis belong to interstitial lung diseases (ILD) where an imbalance of regulatory, profibrotic and antifibrotic cytokines is hypothesized. The relationship of bronchoalveolar lavage (BAL) fluid (BALF) cytokines, BALF cell profile and ILD course is supposed. The aim of our study was to correlate BALF cytokine and chemokine levels with BALF cellular characteristics and lung function parameters in different ILD. Twenty-two sarcoidosis, seven IPF and 11 HP patients underwent lung function tests and BAL. The BALF differential cell counts and superficial cell markers were characterized, and MCP-1, MIP-1α, MIP-1β, RANTES, epithelial neutrophil-activating protein (ENA)-78, FGF, G-CSF, GM-CSF, IFN-γ, interleukin (IL)-1α, IL-1RA, IL-1β, -2β, -4β, -5β, -6β, -8β, -10β, -17β, tumour necrosis factor (TNF)-α, thromobopoietin (Tpo) and vascular endothelial growth factor (VEGF) values measured. The BALF VEGF values were highest in sarcoidosis (P = 0.0526). IL-1RA values were higher in IPF and HP compared with sarcoidosis (P = 0.0334). IL-8/ENA-78 ratio positively correlated with BALF neutrophil counts in IPF (r = 0.89, P = 0.04). Vital capacity and TLCO values positively correlated with VEGF and negatively with IL-8 BALF levels in all ILDs but the correlations were most significant in sarcoidosis group. We suppose that VEGF plays a role in ILDs’ early phases and has rather angiogenic than profibrotic effect. On the contrary, IL-8 is probably upregulated in advanced ILDs with prominent fibrosis and marked lung functions decline. We state that BALF VEGF, IL-8 and ENA-78 levels and IL-8/ENA-78 ratio could become useful markers of ILDs’ phase, activity and prognosis. They might also be helpful in treatment modality choice.Keywords
This publication has 26 references indexed in Scilit:
- Different angiogenic CXC chemokine levels in bronchoalveolar lavage fluid after interferon gamma-1b therapy in idiopathic pulmonary fibrosis patientsPulmonary Pharmacology & Therapeutics, 2008
- CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophagesClinical and Experimental Immunology, 2007
- CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosisArthritis & Rheumatism, 2007
- Different Angiogenic Activity in Pulmonary Sarcoidosis and Idiopathic Pulmonary FibrosisChest, 2006
- CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2005
- The Role of MIP-1? in Experimental Hypersensitivity PneumonitisLung, 2004
- Experimental hypersensitivity pneumonitis: role of MCP-1Journal of Laboratory and Clinical Medicine, 2003
- Angiogenesis in Hypersensitivity PneumonitisArchives of Physiology and Biochemistry, 2003
- Significance of the Interleukin-1 Receptor Antagonist/Interleukin-1β Ratio as a Prognostic Factor in Patients with Pulmonary SarcoidosisRespiration, 2000
- Idiopathic Pulmonary Fibrosis: Diagnosis and TreatmentAmerican Journal of Respiratory and Critical Care Medicine, 2000